MLYS Competitors & Alternatives
Compare Mineralys Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MLYS
Main Stock$15.58
Tradestie Score
56
Market Cap
$3.09B
Analyst Upside
+179.7%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.12
|
$1.50B | 7.3 | 56 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$21.52
|
$1.50B | - | 49 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$30.93
|
$1.49B | - | 45 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$18.67
|
$1.43B | - | 64 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$12.14
|
$1.42B | - | 46 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.60
|
$1.35B | - | 55 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.15
|
$1.32B | - | 58 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.22
|
$1.29B | - | 39 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$27.00
|
$1.29B | - | 44 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.06
|
$1.29B | - | 57 | Compare |
More MLYS Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry